IMGN Annual Shareholders Equity
$155.83 M
-$169.76 M-52.14%
31 December 2022
Summary:
As of January 23, 2025, IMGN annual stockholders equity is $155.83 million, with the most recent change of -$169.76 million (-52.14%) on December 31, 2022. During the last 3 years, it has risen by +$231.95 million (+304.71%).IMGN Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMGN Quarterly Shareholders Equity
$561.60 M
+$70.75 M+14.41%
30 September 2023
Summary:
As of January 23, 2025, IMGN quarterly stockholders equity is $561.60 million, with the most recent change of +$70.75 million (+14.41%) on September 30, 2023. Over the past year, it has increased by +$383.59 million (+215.49%).IMGN Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IMGN Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -52.1% | +215.5% |
| 3 y3 years | +304.7% | +1409.4% |
| 5 y5 years | +970.8% | +1097.7% |
IMGN Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -52.1% | at high |
ImmunoGen Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $561.60 M(+14.4%) |
| June 2023 | - | $490.84 M(+302.6%) |
| Mar 2023 | - | $121.92 M(-21.8%) |
| Dec 2022 | $155.83 M(-52.1%) | $155.83 M(-12.5%) |
| Sept 2022 | - | $178.01 M(-28.7%) |
| June 2022 | - | $249.83 M(-18.5%) |
| Mar 2022 | - | $306.47 M(-5.9%) |
| Dec 2021 | $325.59 M(+263.5%) | $325.59 M(+322.3%) |
| Sept 2021 | - | $77.09 M(+12.6%) |
| June 2021 | - | $68.47 M(-27.3%) |
| Mar 2021 | - | $94.12 M(+5.1%) |
| Dec 2020 | $89.57 M(-217.7%) | $89.57 M(-308.8%) |
| Sept 2020 | - | -$42.89 M(+74.9%) |
| June 2020 | - | -$24.52 M(+497.7%) |
| Mar 2020 | - | -$4.10 M(-94.6%) |
| Dec 2019 | -$76.12 M(-793.8%) | -$76.12 M(-11.7%) |
| Sept 2019 | - | -$86.22 M(+26.5%) |
| June 2019 | - | -$68.17 M(+147.0%) |
| Mar 2019 | - | -$27.60 M(-351.6%) |
| Dec 2018 | $10.97 M(-161.3%) | $10.97 M(-76.6%) |
| Sept 2018 | - | $46.89 M(-47.4%) |
| June 2018 | - | $89.19 M(-345.6%) |
| Mar 2018 | - | -$36.31 M(+102.9%) |
| Dec 2017 | -$17.89 M(-88.3%) | -$17.89 M(-83.9%) |
| Sept 2017 | - | -$111.30 M(-35.8%) |
| June 2017 | - | -$173.23 M(+3.4%) |
| Mar 2017 | - | -$167.53 M(+36.7%) |
| Dec 2016 | -$152.85 M(+85.7%) | - |
| Sept 2016 | - | -$122.54 M(+48.9%) |
| June 2016 | -$82.30 M(-334.5%) | -$82.30 M(+100.0%) |
| Mar 2016 | - | -$41.14 M(+146.6%) |
| Dec 2015 | - | -$16.69 M(-243.7%) |
| Sept 2015 | - | $11.61 M(-66.9%) |
| June 2015 | $35.10 M(-53.6%) | $35.10 M(-41.2%) |
| Mar 2015 | - | $59.67 M(-23.0%) |
| Dec 2014 | - | $77.47 M(+31.4%) |
| Sept 2014 | - | $58.97 M(-22.1%) |
| June 2014 | $75.70 M(-37.9%) | $75.70 M(-22.7%) |
| Mar 2014 | - | $97.93 M(-24.7%) |
| Dec 2013 | - | $130.04 M(+8.9%) |
| Sept 2013 | - | $119.44 M(-2.0%) |
| June 2013 | $121.85 M(+45.2%) | $121.85 M(-12.3%) |
| Mar 2013 | - | $139.00 M(+2.2%) |
| Dec 2012 | - | $136.00 M(-13.6%) |
| Sept 2012 | - | $157.31 M(+87.5%) |
| June 2012 | $83.89 M(-40.1%) | $83.89 M(-16.9%) |
| Mar 2012 | - | $100.93 M(-12.5%) |
| Dec 2011 | - | $115.34 M(-6.8%) |
| Sept 2011 | - | $123.77 M(-11.6%) |
| June 2011 | $139.97 M(+37.2%) | $139.97 M(+115.9%) |
| Mar 2011 | - | $64.82 M(-17.1%) |
| Dec 2010 | - | $78.18 M(-13.6%) |
| Sept 2010 | - | $90.52 M(-11.3%) |
| June 2010 | $102.05 M(+52.6%) | $102.05 M(+183.9%) |
| Mar 2010 | - | $35.95 M(-22.4%) |
| Dec 2009 | - | $46.32 M(-17.8%) |
| Sept 2009 | - | $56.35 M(-15.7%) |
| June 2009 | $66.86 M(+20.9%) | $66.86 M(+75.8%) |
| Mar 2009 | - | $38.03 M(-7.6%) |
| Dec 2008 | - | $41.17 M(-13.1%) |
| Sept 2008 | - | $47.36 M(-14.4%) |
| June 2008 | $55.30 M(-5.3%) | $55.30 M(+33.4%) |
| Mar 2008 | - | $41.46 M(-22.0%) |
| Dec 2007 | - | $53.14 M(-8.5%) |
| Sept 2007 | - | $58.06 M(-0.6%) |
| June 2007 | $58.40 M | $58.40 M(-5.5%) |
| Mar 2007 | - | $61.80 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | - | $64.91 M(-3.1%) |
| Sept 2006 | - | $66.98 M(-7.4%) |
| June 2006 | $72.35 M(-16.7%) | $72.35 M(-7.7%) |
| Mar 2006 | - | $78.42 M(-2.1%) |
| Dec 2005 | - | $80.14 M(-3.4%) |
| Sept 2005 | - | $82.97 M(-4.5%) |
| June 2005 | $86.84 M(-10.6%) | $86.84 M(-2.9%) |
| Mar 2005 | - | $89.41 M(-3.3%) |
| Dec 2004 | - | $92.49 M(-2.3%) |
| Sept 2004 | - | $94.65 M(-2.6%) |
| June 2004 | $97.14 M(-5.4%) | $97.14 M(+0.5%) |
| Mar 2004 | - | $96.62 M(-0.7%) |
| Dec 2003 | - | $97.26 M(-1.3%) |
| Sept 2003 | - | $98.50 M(-4.1%) |
| June 2003 | $102.68 M(-23.5%) | $102.68 M(-6.5%) |
| Mar 2003 | - | $109.77 M(-7.7%) |
| Dec 2002 | - | $118.93 M(-7.1%) |
| Sept 2002 | - | $128.07 M(-4.6%) |
| June 2002 | $134.22 M(-5.8%) | $134.22 M(-2.6%) |
| Mar 2002 | - | $137.83 M(-3.6%) |
| Dec 2001 | - | $143.01 M(-2.7%) |
| Sept 2001 | - | $147.03 M(+3.2%) |
| June 2001 | $142.45 M(+826.9%) | $142.45 M(-5.3%) |
| Mar 2001 | - | $150.43 M(-1.6%) |
| Dec 2000 | - | $152.86 M(+413.4%) |
| Sept 2000 | - | $29.78 M(+93.8%) |
| June 2000 | $15.37 M(+190.0%) | $15.37 M(+8.2%) |
| Mar 2000 | - | $14.21 M(+14.6%) |
| Dec 1999 | - | $12.40 M(+19.2%) |
| Sept 1999 | - | $10.40 M(+96.2%) |
| June 1999 | $5.30 M(+23.3%) | $5.30 M(+17.8%) |
| Mar 1999 | - | $4.50 M(+4.7%) |
| Dec 1998 | - | $4.30 M(-15.7%) |
| Sept 1998 | - | $5.10 M(+18.6%) |
| June 1998 | $4.30 M(-4.4%) | $4.30 M(-15.7%) |
| Mar 1998 | - | $5.10 M(-3.8%) |
| Dec 1997 | - | $5.30 M(+17.8%) |
| Sept 1997 | - | $4.50 M(0.0%) |
| June 1997 | $4.50 M(+66.7%) | $4.50 M(-15.1%) |
| Mar 1997 | - | $5.30 M(+15.2%) |
| Dec 1996 | - | $4.60 M(+170.6%) |
| Sept 1996 | - | $1.70 M(-37.0%) |
| June 1996 | $2.70 M(-73.3%) | $2.70 M(-6.9%) |
| Mar 1996 | - | $2.90 M(-40.8%) |
| Dec 1995 | - | $4.90 M(-51.5%) |
| Sept 1995 | - | $10.10 M(0.0%) |
| June 1995 | $10.10 M(-66.3%) | $10.10 M(-28.4%) |
| Mar 1995 | - | $14.10 M(-42.2%) |
| Sept 1994 | - | $24.40 M(-18.7%) |
| June 1994 | $30.00 M(-25.9%) | $30.00 M(-17.8%) |
| Mar 1994 | - | $36.50 M(+23.7%) |
| Dec 1993 | - | $29.50 M(-17.4%) |
| Sept 1993 | - | $35.70 M(-11.9%) |
| June 1993 | $40.50 M(-31.5%) | $40.50 M(-11.6%) |
| Mar 1993 | - | $45.80 M(-9.1%) |
| Dec 1992 | - | $50.40 M(-8.9%) |
| Sept 1992 | - | $55.30 M(-6.4%) |
| June 1992 | $59.10 M(+40.7%) | $59.10 M(-6.6%) |
| Mar 1992 | - | $63.30 M(+65.7%) |
| Sept 1991 | - | $38.20 M(-9.0%) |
| June 1991 | $42.00 M(+244.3%) | $42.00 M(+0.7%) |
| Mar 1991 | - | $41.70 M(+353.3%) |
| Dec 1990 | - | $9.20 M(-23.3%) |
| Sept 1990 | - | $12.00 M(-1.6%) |
| June 1990 | $12.20 M(+74.3%) | $12.20 M(-17.0%) |
| Mar 1990 | - | $14.70 M(+177.4%) |
| Sept 1989 | - | $5.30 M(-24.3%) |
| June 1989 | $7.00 M | $7.00 M |
FAQ
- What is ImmunoGen annual stockholders equity?
- What is the all time high annual shareholders equity for ImmunoGen?
- What is ImmunoGen annual shareholders equity year-on-year change?
- What is ImmunoGen quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for ImmunoGen?
- What is ImmunoGen quarterly shareholders equity year-on-year change?
What is ImmunoGen annual stockholders equity?
The current annual shareholders equity of IMGN is $155.83 M
What is the all time high annual shareholders equity for ImmunoGen?
ImmunoGen all-time high annual stockholders equity is $325.59 M
What is ImmunoGen annual shareholders equity year-on-year change?
Over the past year, IMGN annual stockholders equity has changed by -$169.76 M (-52.14%)
What is ImmunoGen quarterly stockholders equity?
The current quarterly shareholders equity of IMGN is $561.60 M
What is the all time high quarterly shareholders equity for ImmunoGen?
ImmunoGen all-time high quarterly stockholders equity is $561.60 M
What is ImmunoGen quarterly shareholders equity year-on-year change?
Over the past year, IMGN quarterly stockholders equity has changed by +$383.59 M (+215.49%)